News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Chien Jennifer
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/09/2023 |
4
| Lee Jennifer Kayden (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 11,223 shares
@ $24.1778, valued at
$271.3k
Sold 1,718 shares
@ $24.66, valued at
$42.4k
Exercised 8,591 options to buy
@ $6.8, valued at
$58.4k
Exercised 1,718 options to buy
@ $6.8, valued at
$11.7k
|
|
08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
02/14/2023 |
4
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 635 shares
@ $26.87, valued at
$17.1k
Exercised 2,031 restricted stock units
@ $0 |
|
02/14/2023 |
4/A
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 1,204 shares
@ $27.51, valued at
$33.1k
|
|
02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/15/2022 |
4
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Sold 722 shares
@ $6.1, valued at
$4.4k
Exercised 2,032 restricted stock units
@ $0 |
|
02/11/2022 |
4
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Granted 13,750 restricted stock units
@ $0 Granted 82,500 options to buy
@ $6.8, valued at
$561k
|
|
11/10/2020 |
4
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
Txns:
| Granted 100,000 options to buy
@ $24.29, valued at
$2.4M
|
|
11/10/2020 |
3
| Chien Jennifer (EVP, Head of North America) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC. |
02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2020 |
3
| Chien Jennifer (Chief Commercial Officer) has filed a Form 3 on Krystal Biotech, Inc. |
|
|